IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 15452 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1State-of-the-Art: Inflammatory and Metabolic Markers in Mood Disorders
Federico Mucci,Donatella Marazziti,Alessandra Della Vecchia,Stefano Baroni,Paolo Morana,Barbara Carpita,Paola Mangiapane,Florinda Morana,Benedetto Morana,Liliana Dell’Osso
2Convergent lines of evidence support the role of uric acid levels as a potential biomarker in bipolar disorder
Rodrigo Machado-Vieira,Haitham Salem,Benicio N Frey,Izabela G Barbosa,Antonio L Teixeira
Expert Review of Molecular Diagnostics.2017;17(2)107
3Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics
Robin Ortiz,Henning Ulrich,Carlos A. Zarate,Rodrigo Machado-Vieira
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2015;57(2)117
4Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders
Luiz Gustavo Piccoli de Melo,Sandra Odebrecht Vargas Nunes,George Anderson,Heber Odebrecht Vargas,Décio Sabbattini Barbosa,Piotr Galecki,André F. Carvalho,Michael Maes
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2017;78(2)34
5Serum uric acid levels in first episode mania, effect on clinical presentation and treatment response: Data from a case control study
Seshadri Sekhar Chatterjee,Sutanuka Ghosal,Sayantanava Mitra,Nitu Mallik,Malay Kumar Ghosal
Asian Journal of Psychiatry.2018;35(2)15
6Antidepressant-like effects of the xanthine oxidase enzyme inhibitor allopurinol in rats. A comparison with fluoxetine
Börte Gürbüz Özgür,Hatice Aksu,Mustafa Birincioglu,Turhan Dost
Pharmacology Biochemistry and Behavior.2015;138(2)91
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow